Afaf Osman, MD (@afafosman7) 's Twitter Profile
Afaf Osman, MD

@afafosman7

Hematologist. Leukemia, clonal hematopoiesis and MDS.

ID: 1024366977425526784

calendar_today31-07-2018 18:51:34

514 Tweet

576 Followers

630 Following

NMDP (@nmdp_org) 's Twitter Profile Photo

Kyle needs our help! ⚠️ Diagnosed with leukemia right before his UCR Men's Basketball senior night game, he now urgently needs a blood stem cell transplant. No matches have been found yet, but your cells could be his cure. Join the registry today or share his story 👉 bit.ly/48hirIj

Kyle needs our help! ⚠️ Diagnosed with leukemia right before his <a href="/UCRMBB/">UCR Men's Basketball</a> senior night game, he now urgently needs a blood stem cell transplant. No matches have been found yet, but your cells could be his cure. Join the registry today or share his story 👉 bit.ly/48hirIj
Eric Topol (@erictopol) 's Twitter Profile Photo

This week's nature editorial The missed opportunities to save lives with genomic data, such as mutations in BRCA1 and 2 nature.com/articles/d4158…

This week's <a href="/Nature/">nature</a>  editorial
The missed opportunities to save lives with genomic data, such as mutations in BRCA1 and 2
nature.com/articles/d4158…
Afaf Osman, MD (@afafosman7) 's Twitter Profile Photo

This test is widely available nowadays so its important to know the implications of an abnormal study. My amazing friend Shiela Rajagopal is not on twitter but she contributed to this important project. Glad the publication is in NEJM!

Huntsman Cancer Institute (@huntsmancancer) 's Twitter Profile Photo

HCI researchers Jihyun Song, PhD, and Josef Prchal, MD, have identified a gene variant in a high-altitude Andean population that could predict disease severity and treatment responses in certain blood cancers. bit.ly/4ipa0iV UofUHeme

HCI researchers Jihyun Song, PhD, and Josef Prchal, MD, have identified a gene variant in a high-altitude Andean population that could predict disease severity and treatment responses in certain blood cancers. bit.ly/4ipa0iV

<a href="/UofUHematology/">UofUHeme</a>
Aref Al-Kali (@alkalidr) 's Twitter Profile Photo

Pre-HCT #KMT2A MRD by PCR is prognostic for relapse and survival @BloodJournal Pretransplant MRD detection of fusion transcripts is strongly prognostic in KMT2A-rearranged acute myeloid leukemia ashpublications.org/blood/article-…

National Cancer Institute (@thenci) 's Twitter Profile Photo

Cancer survivors are growing in number. In the US, nearly half of survivors have lived 10 or more years after diagnosis, while 19% have lived 20 or more years. The prevalence of long-term survivors is expected to increase through 2040. go.nih.gov/rOUbZJD #CancerSurvivorship

Cancer survivors are growing in number. In the US, nearly half of survivors have lived 10 or more years after diagnosis, while 19% have lived 20 or more years. The prevalence of long-term survivors is expected to increase through 2040. go.nih.gov/rOUbZJD #CancerSurvivorship
KSL 5 TV (@ksl5tv) 's Twitter Profile Photo

The Red Cross of Utah is urging locals to donate blood after severe winter storms caused over 250 Red Cross blood drives to be canceled nationwide. ksltv.com/724169/red-cro…

SWOG Cancer Research Network (@swog) 's Twitter Profile Photo

#myeloMATCH MM1YA-S01 is enrolling adults ages 18-59 with newly diagnosed high-risk #AML. Randomized 5-arm comparison of induction therapies. Primary endpoint: MRD-negative complete remission rate. SWOG.org/clinical-trial… Co-PI: Tara Lin, MD KU Cancer Center #leusm #AMLsm

#myeloMATCH MM1YA-S01 is enrolling adults ages 18-59 with newly diagnosed high-risk #AML.
Randomized 5-arm comparison of induction therapies. Primary endpoint: MRD-negative complete remission rate. SWOG.org/clinical-trial…
Co-PI: Tara Lin, MD <a href="/KUcancercenter/">KU Cancer Center</a> #leusm #AMLsm
MashupMD (@mdmashup) 's Twitter Profile Photo

New therapeutic targets in MDS were highlighted at #ASH24, with promising early-phase trials for Elritecept, R289, Vibectomab, and DVF890. Afaf Osman, MD is optimistic about these developments offering new hope for MDS patients in 2025. 👉Read more: mashupmd.com/expert-collect…

New therapeutic targets in MDS were highlighted at #ASH24, with promising early-phase trials for Elritecept, R289, Vibectomab, and DVF890. <a href="/AfafOsman7/">Afaf Osman, MD</a> is optimistic about these developments offering new hope for MDS patients in 2025.

👉Read more: mashupmd.com/expert-collect…
Sudanese American Medical Association - SAMA (@sudamerimedasn) 's Twitter Profile Photo

Sudan faces a historic crisis. Millions displaced, food insecurity soaring. The Humanitarian Relief & Reconstruction Alliance, led by SAMA & WAV, delivered 863,000+ meals to 28,466 IDPs. 📖 Read the impact: sama-sd.org/2025/01/08/sam… ❤️ Donate now: sama-sd.org/donate/

Sudan faces a historic crisis. Millions displaced, food insecurity soaring.

The Humanitarian Relief &amp; Reconstruction Alliance, led by SAMA &amp; WAV, delivered 863,000+ meals to 28,466 IDPs.

📖 Read the impact: sama-sd.org/2025/01/08/sam…
❤️ Donate now: sama-sd.org/donate/
Afaf Osman, MD (@afafosman7) 's Twitter Profile Photo

At some point, someone invested in us. Now it’s our turn. Join me in supporting the #Fight4Hematology and help secure the future of hematology research and care! Support the ASH foundation hematology.org/foundation